MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile

When do Magnesium Sulfate In Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Magnesium Sulfate In Dextrose 5% In Plastic Container is a drug marketed by B Braun Medical Inc, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Hq Spclt Pharma, and Mylan Labs Ltd. and is included in six NDAs.

The generic ingredient in MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER is magnesium sulfate. There are one hundred and forty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Magnesium Sulfate In Dextrose 5% In Plastic Container

A generic version of MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as magnesium sulfate by FRESENIUS KABI USA on September 8^th, 1986.

Summary for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER

US Patents:	0
Applicants:	6
NDAs:	6
Finished Product Suppliers / Packagers:	6
Raw Ingredient (Bulk) Api Vendors:	55
Clinical Trials:	324
DailyMed Link:	MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed

Recent Clinical Trials for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Oklahoma	Early Phase 1
Daewoong Pharmaceutical Co. LTD.	Phase 3
Cairo University	Phase 1/Phase 2

See all MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

Pharmacology for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Drug Class	Calculi Dissolution Agent Osmotic Laxative
Mechanism of Action	Magnesium Ion Exchange Activity Osmotic Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption Inhibition Small Intestine Fluid/Electrolyte Absorption Stimulation Large Intestine Fluid/Electrolyte Secretion

US Patents and Regulatory Information for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun Medical Inc	MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER	magnesium sulfate	INJECTABLE;INJECTION	207966-001	Oct 27, 2020	AP	RX	No	No
Mylan Labs Ltd	MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER	magnesium sulfate	INJECTABLE;INJECTION	209932-001	Sep 10, 2018	AP	RX	No	No
Hospira	MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER	magnesium sulfate	INJECTABLE;INJECTION	020488-001	Jul 11, 1995	AP	RX	Yes	Yes
Baxter Hlthcare Corp	MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER	magnesium sulfate	INJECTABLE;INJECTION	211965-001	Aug 11, 2020	AP	RX	No	No
Fresenius Kabi Usa	MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER	magnesium sulfate	INJECTABLE;INJECTION	206486-001	Mar 7, 2016	AP	RX	No	No